Vanguard Group Inc Kiniksa Pharmaceuticals, Ltd. Transaction History

Vanguard Group Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$17.63 - $21.74 $292,569 - $360,775	16,595 Added 0.56%	2,981,894 $58.8 Million
Q4 2023 Feb 14, 2024	BUY	$14.37 - $19.07 $91,134 - $120,941	6,342 Added 0.21%	2,965,299 $52 Million
Q3 2023 Nov 14, 2023	SELL	$13.62 - $20.2 $1.75 Million - $2.59 Million	-128,255 Reduced 4.15%	2,958,957 $51.4 Million
Q2 2023 Aug 14, 2023	SELL	$10.44 - $16.48 $1.81 Million - $2.86 Million	-173,411 Reduced 5.32%	3,087,212 $43.5 Million
Q1 2023 May 15, 2023	BUY	$10.7 - $15.79 $360,932 - $532,628	33,732 Added 1.05%	3,260,623 $35.1 Million
Q4 2022 Feb 10, 2023	BUY	$11.42 - $17.05 $1.69 Million - $2.52 Million	147,699 Added 4.8%	3,226,891 $48.3 Million
Q3 2022 Nov 14, 2022	BUY	$9.76 - $13.41 $1.48 Million - $2.03 Million	151,211 Added 5.16%	3,079,192 $39.5 Million
Q2 2022 Aug 12, 2022	SELL	$7.6 - $11.41 $597,884 - $897,613	-78,669 Reduced 2.62%	2,927,981 $28.4 Million
Q1 2022 May 13, 2022	BUY	$9.3 - $12.37 $1.08 Million - $1.43 Million	115,942 Added 4.01%	3,006,650 $29.9 Million
Q4 2021 Feb 14, 2022	BUY	$10.39 - $15.15 $2.37 Million - $3.46 Million	228,082 Added 8.57%	2,890,708 $34 Million
Q3 2021 Nov 12, 2021	SELL	$11.39 - $16.23 $19,328 - $27,542	-1,697 Reduced 0.06%	2,662,626 $30.3 Million
Q2 2021 Aug 13, 2021	BUY	$13.22 - $19.09 $35.2 Million - $50.9 Million	2,664,323 New	2,664,323 $37.1 Million

1.89M

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $862M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.